Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
HU-444 by 180 Life Sciences for Pain: Likelihood of Approval
HU-444 is under clinical development by 180 Life Sciences and currently in Phase I for Pain. According to GlobalData, Phase...